Better efficacy in inducing IFN-γ-producing CTL-mediated cytotoxicity than non-CD90-sorted irradiated HepG2 cell-fused DC vaccineBetter efficacy in suppressing tumor growth than non-CD90-sorted irradiated HepG2 cell-fused DC vaccine. The gene discussed is THY1; the disease is neoplasm.